Since it seems to be accepted practice now to accuse anyone who doesn't
think your stock is a screaming buy today with being "secretly short",
let me be very clear from the get-go - I like Endologix (ELGX)
quite a lot as a company, I think the company's technology is
innovative, and I see the company as both a share-gainer in endovascular
AAA treatment and one of the best growth stories today in med-tech. All
of that said, I don't see it as a bargain unless/until a larger
med-tech company decides that it must have it as its own.
Please continue here:
Endologix Shows How Growth-Hungry Med-Tech Investors Are
No comments:
Post a Comment